medigraphic.com
ISSN 1560-4381 (Impreso)

2021, Número 1

<< Anterior Siguiente >>

Correo Científico Médico 2021; 25 (1)


Carcinogénesis bucal

Sánchez SRJ, Sigcho RCR, Bermúdez GAJ, Serrano GNB, Teruel GR

Idioma: Español
Referencias bibliográficas: 48
Paginas: 1-23
Archivo PDF: 319.33 Kb.


RESUMEN

El cáncer bucal es una neoplasia maligna multifactorial donde la predisposición genética a la enfermedad se relaciona con factores del ambiente para desarrollar un cáncer con evolución lenta y signos inespecíficos. Esta revisión bibliográfica se realizó en PMC de US National Library of Medicine y National Institutes of Health (https://www.ncbi.nlm.nih.gov/pmc), en Cancer Biology de Annual Reviews (https://www.annualreviews.org), en Clinical Key (https://www.clinicalkey.com) y en Infomed (www.sld.cu), con el descriptor oral cancer. Se describe la carcinogénesis bucal y los factores causales de los cambios en el material genético que origina la transformación cancerosa mediante la activación de proto-oncogenes a oncogenes y la inactivación de genes supresores tumorales.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Rivera C. Essentials of oral cancer. Int J Clin Exp Pathol. 2015[citado 15/05/2019]; 8(9):11884-11894. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637760/pdf/ijcep0008-11884.pdf

  2. Hernandes Rocha TA, Erika Bárbara Abreu Fonseca Thomaz EB,Cristina da Silva N, Christine de Sousa Queiroz R,Rovery de Souza M, Queiroz Barbosa AC, at al. Oral primary care: an analysis of its impact on the incidence and mortality rates of oral cancer. BMC Cancer. 2017[citado 15/05/2019];17:706. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661925/pdf/12885_2017_Article_3700.pdf

  3. Dhanuthai K, Rojanawatsirivej S, Thosaporn W, Kintarak S, Subarnbhe-saj A, Darling M, et al. Oral cancer: A multicenter study.Med Oral Patol Oral Cir Bucal. 2018 [citado 25/08/2019];23(1):e23-29.Disponible en: http://www.medicinaoral.com/medoralfree01/v23i1/medoralv23i1p23.pdf

  4. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018[citado 18/05/2019];68(6):394–424. Disponible en: https://acsjournals.onlinelibrary.wiley.com/doi/epdf/10.3322/caac.21492

  5. 5 Cuba. Ministerio de Salud Pública. Anuario estadístico de Cuba. La Habana: MINSAP; 2019[citado 25/09/2020]. Disponible en: http://files.sld.cu/bvscuba/files/2019/04/Anuario-Electr%C3%B3nico-Espa%C3%B1ol-2018-ed-2019-compressed.pdf

  6. Verdecia Jiménez AI, Álvarez Infantes E, Parra Lahens J. Mortalidad por cáncer bucal en pacientes de la provincia Holguín. CCM.2014[citado 01/20/2020];18(1).Disponible en: http://www.revcocmed.sld.cu/index.php/cocmed/article/view/1479

  7. Castillo Santiesteban Y, Zaldívar Pupo OL, Leyva Infante M, Páez González Y. Comportamiento del cáncer bucal en pacientes adultos mayores, Holguín, Cuba. CCM. 2018 [citado 01/05/2020];22(3).Disponible en: http://www.revcocmed.sld.cu/index.php/cocmed/article/view/2868

  8. Karjoo Z, Chen X, Hatefi A. Progress and Problems with the Use of Suicide Genes for Targeted Cancer Therapy. Adv Drug Deliv Rev. 2016[citado 15/02/2019]; 99(Pt A):113–128. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758904

  9. Monteiro de Oliveira Novaes JA, William WN. Prognostic factors, predictive markers and cancer biology: the triad for successful oral cancer chemoprevention. Future Oncol.2016 [citado 25/05/2019];12(20):2379–2386.Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066140/pdf/fon-12-2379.pdf

  10. Salvatierra Cáceres E, Salinas Rodríguez J, Hidalgo Rivas A, Sánchez Astorga M. Capacidad diagnóstica de los biomarcadores salivales interleucinas 6 y 8 para el diagnóstico de carcinoma de células escamosas de cavidad oral. Av Odontoestomatol.2017 [citado 05/04/2020]; 33(2):67-75. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0213-12852017000200003&lng=es

  11. Letai A. Apoptosis and Cancer.Annu Rev Cáncer Biol. 2017[citado 04/08/2019];1: 275–294. Disponible en: https://www.annualreviews.org/doi/pdf/10.1146/annurev-cancerbio-050216-121933

  12. Nelson DL, Cox MM. Leningher Principles of Biochemistry.7a ed. New York: W. H. Freeman and Macmillan Higher Education; 2017.

  13. Hnisz D, Schuijers J, Li CH, Young RA. Regulation and Dysregulation of Chromosome Structure in Cancer. Annu Rev Cancer Biol. 2018[citado 04/08/2019];2:21–40. Disponible en: https://www.annualreviews.org/doi/pdf/10.1146/annurev-cancerbio-030617-050134

  14. Murray RK, Bender DA, Botham KM, Kennelly PJ, Rodwell VW, Weil PA. Harper's Illustrated Biochemistry. 29th. USA: McGraw-Hill; 2012.

  15. Miguel Cruz PA, Niño Peña A, Batista Marrero K, Miguel Soca PE. Factores de riesgo de cáncer bucal. Rev Cubana Estomatol. 2016[citado 03/11/2019];53(3): 128-145. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75072016000300006&lng=es

  16. Bermúdez Garcell A, Serrano Gámez NB, Teruel Ginés R, Sánchez Sánchez R, Sigcho Romero CR. Mecanismos básicos de la epigenética.CCM.2020[citado 05/04/2020];24(1). Disponible en: http://www.revcocmed.sld.cu/index.php/cocmed/article/view/3448

  17. Wen G, Wang H, Zhong Z. Associations of RASSF1A, RARb, and CDH1 promoter hypermethylation with oral cancer risk. A PRISMA-compliant meta-analysis. Medicine. 2018[citado 15/06/2020];97(11):9971. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882397/pdf/medi-97-e9971.pdf

  18. Iulia Irimie A, Ciocan C, Gulei D, Mehterov N, Atanasov A, Dudea D, et al. Current Insights into Oral Cancer Epigenetics. Int J Mol Sci. 2018[citado 15/02/2020]; 19(3):670. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877531/pdf/ijms-19-00670.pdf

  19. Yakin M, Osea Gavidi R, Cox B, Rich A. Oral cancer risk factors in New Zealand. N Z Med J. 2017[citado 15/05/2019];130 (1451):30-38. Disponible en: https://researchoutput.csu.edu.au/ws/portalfiles/portal/10943197/10943169_Published_article.pdf

  20. Salan AI, Camen A, Ciuca A, Patru A, Scrieciu M, Popescu SM, et al. Epidemiological Aspects in Lip Tumors in Oltenia Region of Romania During 2012-2016. Curr Health Sci J. 2018[citado 15/02/2019];44(1):39-47.Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295190

  21. Ishida K, Tomita H, Nakashima T, Hirata A, Tanaka T, Shibata T, et al. Current mouse models of oral squamous cell carcinoma: Genetic and chemically induced models. Oral Oncol. 2017[citado 25/05/2019];73:16-20.Disponible en: https://www.clinicalkey.es/#!/content/playContent/1-s2.0-S1368837517302191?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1368837517302191%3Fshowall%3Dtrue&referrer

  22. McCreery MQ, Balmain A. Chemical Carcinogenesis Models of Cancer: Back to the Future. Annu Rev Cancer Biol. 2017[citado 15/05/2019];1:295–312.Disponible en: https://www.annualreviews.org/doi/pdf/10.1146/annurev-cancerbio-050216-122002

  23. Dhanuthai K, Rojanawatsirivej S, Thosaporn W, Kintarak S, Subarnbhesaj A, Darling M, et al. Oral cancer: A multicenter study. Med Oral Patol Oral Cir Bucal. 2018[citado 15/05/2020];23(1):23-29.Disponible en: http://dx.doi.org/doi:10.4317/medoral.21999

  24. Manvikar V, Kulkarni R, Koneru A, Vanishree M. Role of human papillomavirus and tumor suppressor genes in oral cancer. J Oral Maxillofac Pathol.2016[citado 25/09/2020];20(1):106–110.Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860909/?report=classic

  25. Sreekumar VN. Global Scenario of Research in Oral Cancer. J Maxillofac Oral Surg. 2019[citado 29/03/2020];18(3):354–359.Disponible en: https://link.springer.com/article/10.1007/s12663-018-1166-4

  26. Varmus H. How Tumor Virology Evolved into Cancer Biology and Transformed Oncology. Annu Rev Cancer Biol. 2017[citado 06/03/2019];1:1–18.Disponible en: https://www.annualreviews.org/doi/pdf/10.1146/annurev-cancerbio-050216-034315

  27. Min Kim S. Human papilloma virus in oral cancer. J Korean Assoc Oral Maxillofac Surg. 2016[citado 15/07/2019];42(6):327-336.Disponible en: https://doi.org/10.5125/jkaoms.2016.42.6.327

  28. Chi A, Day T, Neville B. Oral Cavity and Oropharyngeal Squamous Cell Carcinoma—An Update. CA Cancer J Clin. 2015[citado 25/08/2019];65(5):401–421.Disponible en: https://acsjournals.onlinelibrary.wiley.com/doi/epdf/10.3322/caac.21293

  29. Rebolledo Cobos M, Arango Fernández H, Rebolledo Cobos R, Alonso Brujes I. Role of human papillomavirus in the development of oral carcinoma: a review. Av Odontoestomatol. 2016[citado 02/05/2019];32(3):135-144. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0213-12852016000300002&lng=es

  30. Bano N, Yadav M, Mohania D, Das B. The role of NF-κB and miRNA in oral cancer and cancer stem cells with or without HPV16 infection. PLoS One. 2018[citado 25/07/2019]; 13(10):0205518. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30372446/

  31. Chuerduangphui J, Pientong C, Patarapadungkit N, Chotiyano A, Vatanasapt P, Kongyingyoes B, et al. Amplification of EGFR and cyclin D1 genes associated with human papillomavirus infection in oral squamous cell carcinoma. Med Oncol.2017[citado 15/10/2019];34(9):148.Disponible en: https://europepmc.org/article/med/28741068

  32. Krishna A, Singh S, Kumar V. Molecular concept in human oral cancer. Natl J Maxillofac Surg. 2015[citado 25/11/2019];6(1): 9–15.Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4668742/?report=reader

  33. Jain M. Assesment of Correlation of Herpes Simplex Virus-1 with Oral Cancer and Precancer- A Comparative Study. J Clin Diagnostic Res. 2016[citado 25/06/2019];10(8):14-17.Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028589/pdf/jcdr-10-ZC14.pdf

  34. Chattopadhyay I, Verma M, Panda M. Role of Oral Microbiome Signatures in Diagnosis and Prognosis of Oral Cancer. Technol Cancer Res Treat.2019[citado 25/09/2019];18:1-19. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676258/pdf/10.1177_1533033819867354.pdf

  35. Perera M, Al-hebshi NN, Speicher DJ, Perera I, Johnson NW. Emerging role of bacteria in oral carcinogenesis: a review with special reference to perio-pathogenic bacteria. J Oral Microbiol. 2016[citado 25/09/2020];8:32762.Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039235/pdf/JOM-8-32762.pdf

  36. Colbert Maresso K, Tsai K, Brown P, Szabo E, Lippman S, Hawk E. Molecular Cancer Prevention: Current Status and Future Directions. CA Cancer J Clin. 2015[citado 25/08/2019]; 65(5):345-383.Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820069/

  37. Peng Q, Deng Z, Pan H, Gu L, Liu O, Tang Z. Mitogen-activated protein kinase signaling pathway in oral cancer (Review). Oncol Letters.2018 [citado 25/08/2020];15(2):1379-1388.Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5776165/

  38. Kumar R, Samal S, Routray S, Dash R, Dixit A. Identification of oral cancer related candidate genes by integrating protein-protein interactions, gene ontology, pathway analysis and immunohistochemistry. Sci Rep. 2017[citado 15/05/2020];7:2472. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449392/?report=reader

  39. Bermúdez Garcell A, Serrano Gámez NB, Teruel Ginés R, Leyva Montero Md, Naranjo Coronel AA. Biología del cáncer.CCM.2019 [citado 25/05/2020];23(4).Disponible en: http://www.revcocmed.sld.cu/index.php/cocmed/article/view/3350

  40. Saintigny P, William WN, Foy JF, Papadimitrakopoulou V, Lang W, Zhang L, et al. Met Receptor Tyrosine Kinase and Chemoprevention of Oral Cancer. JNCI J Natl Cancer Inst. 2018; 110(3): djx186. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946820/pdf/djx186.pdf

  41. Adeola H, Soyele O, Adefuye A, Jimoh S, Butali A. Omics-based molecular techniques in oral pathology centred cancer: prospect and challenges in Africa. Cancer Cell Int. 2017[citado 15/05/2019]; 17: 61. Disponible en: https://cancerci.biomedcentral.com/articles/10.1186/s12935-017-0432-8

  42. Bundela S, Sharma A, Bisen P. Potential Therapeutic Targets for Oral Cancer: ADM, TP53, EGFR, LYN, CTLA4, SKIL, CTGF, CD70. PLoS ONE. 2014[citado 15/02/2020];9(7):102610. Disponible en: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0102610

  43. Miguel-Soca P, Argüelles González I, Peña González M. Factores genéticos en la carcinogénesis mamaria. Finlay.2016 [citado 20/20/2020];6(4): 299-316. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S2221-24342016000400007&lng=es

  44. Todd R, McBride J, Tsuji T, Donoff RB, Nagai M, Chou MY, et al. Deleted in oral cancer-1 (doc-1), a novel oral tumor suppressor gene. Fased J. 1995[citado 15/08/02019];9(13):1362-1370.Disponible en: https://faseb.onlinelibrary.wiley.com/doi/abs/10.1096/fasebj.9.13.7557027

  45. Sherr C, Bartek J. Cell Cycle–Targeted Cancer Therapies. Annu Rev Cancer Biol. 2017[citado 25/08/2020];1:41–57. Disponible en: https://www.annualreviews.org/doi/pdf/10.1146/annurev-cancerbio-040716-075628

  46. Chakraborty P, Karmakar T, Arora N, Mukherjee G. Immune and genomic signatures in oral (head and neck) cancer. Heliyon.2018[citado 15/05/2020];4(10): 00880.Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218671/pdf/main.pdf

  47. Rajendiran S, Kpetemey M, Maji S, Gibbs LD, Dasgupta S, Mantsch R, et al. MIEN1 promotes oral cancer progression and implicates poor overall survival. Cancer Biol Ther. 2015[citado 25/05/2020];16(6):876-885.Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622880/pdf/kcbt-16-06-1040962.pdf

  48. Zhang X, Zhang L, Tan X, Lin Y, Han X, Huadong Wang H, et al. Systematic analysis of genes involved in oral cancer metastasis to lymph nodes. Cell Mol Biol Lett.2018[citado 15/05/2020];23:53. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237046/




2020     |     www.medigraphic.com